Clara Feider
Sr. Clinical Research Associate
Clara Feider is a Ph.D. and a Certified Clinical Research Associate working at CovarsaDx. Her passion for developing and evaluating medical devices and diagnostics has fueled her work in the clinical research space for the past eight years.
At CovarsaDx, she is responsible for monitoring and managing clinical sites and supporting the clinical studies of in vitro diagnostics. She also performs site visits which include qualification, initiation, and interim monitoring as well as close out visits that are done on site and remotely. She compiles reports for on site visits and prepares materials for clinical site training and study management. This includes SIV slides, site work instructions, shipping records, and study logs.
Clara also provides clinical site training to ensure that studies are conducted according to protocols and in compliance with Good Clinical Practice (GCP) as well as Food and Drug Administration (FDA) regulations.
She obtained her Ph.D. in Analytical Chemistry in 2020 from the University of Texas in Austin. Since then, Clara has focused on developing novel disease diagnosis methods and intraoperative cancer resection tools. She is keenly interested in the end-to-end clinical research process — from early development to post-market evaluation and has a particular enthusiasm for clinical monitoring and clinical trial execution.
At CovarsaDx, she is responsible for monitoring and managing clinical sites and supporting the clinical studies of in vitro diagnostics. She also performs site visits which include qualification, initiation, and interim monitoring as well as close out visits that are done on site and remotely. She compiles reports for on site visits and prepares materials for clinical site training and study management. This includes SIV slides, site work instructions, shipping records, and study logs.
Clara also provides clinical site training to ensure that studies are conducted according to protocols and in compliance with Good Clinical Practice (GCP) as well as Food and Drug Administration (FDA) regulations.
She obtained her Ph.D. in Analytical Chemistry in 2020 from the University of Texas in Austin. Since then, Clara has focused on developing novel disease diagnosis methods and intraoperative cancer resection tools. She is keenly interested in the end-to-end clinical research process — from early development to post-market evaluation and has a particular enthusiasm for clinical monitoring and clinical trial execution.
Clara previously worked as a consultant for an early-stage medical device startup. During her time there, she helped advance business, regulatory, and product development plans. She was also part of the teams that sought authorization for several COVID-19 antigen tests.
Clara is named on two pending patent applications, “Using Mass Spectrometry to Identify Endometriosis Tissue“ and “Detecting Chemical Compounds for Forensic Analysis.”
Clara is an active member of the Association of Clinical Research Professionals (ACRP) and the Regulatory Affairs Professionals Society (RAPS).
Clara is named on two pending patent applications, “Using Mass Spectrometry to Identify Endometriosis Tissue“ and “Detecting Chemical Compounds for Forensic Analysis.”
Clara is an active member of the Association of Clinical Research Professionals (ACRP) and the Regulatory Affairs Professionals Society (RAPS).